Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
149
datasets available to search
ShareScore release 0.9.0
Dataset results
149 results for “vedolizumab”
Postmarketing Vedolizumab Milk-Only Lactation Study in Lactating Women With Active Ulcerative Colitis or Crohn's Disease
ClinicalTrials.gov study NCT02559713. IPD Sharing: YES. Countries: 1. Publications: 1.
Special Drug-Use Surveillance Study on Vedolizumab for IV Infusion 300 mg [Ulcerative Colitis]
ClinicalTrials.gov study NCT03824561. IPD Sharing: YES. Countries: 1. Publications: 1.
Efficacy and Safety of Vedolizumab Subcutaneously (SC) as Maintenance Therapy in Ulcerative Colitis
ClinicalTrials.gov study NCT02611830. IPD Sharing: YES. Countries: 31. Publications: 3.
A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease
ClinicalTrials.gov study NCT02620046. IPD Sharing: YES. Countries: 33. Publications: 1.
An Open-label Study of Vedolizumab (MLN0002) in Participants With Ulcerative Colitis and Crohn's Disease
ClinicalTrials.gov study NCT00790933. IPD Sharing: YES. Countries: 10. Publications: 6.
Vedolizumab in the Prophylaxis of Intestinal Acute Graft Versus Host Disease (aGVHD) in Participants Undergoing Allogeneic Hematopoietic Stem Cell (Allo-HSCT) Transplantation
ClinicalTrials.gov study NCT03657160. IPD Sharing: YES. Countries: 27. Publications: 1.
Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn's Disease
ClinicalTrials.gov study NCT02743806. IPD Sharing: YES. Countries: 18. Publications: 1.
A Study to Evaluate the Efficacy and Safety of Vedolizumab in the Treatment of Chronic Pouchitis
ClinicalTrials.gov study NCT02790138. IPD Sharing: YES. Countries: 9. Publications: 2.
Study of Relationship Between Vedolizumab Therapeutic Drug Monitoring, Biomarkers of Inflammation and Clinical Outcomes
ClinicalTrials.gov study NCT04567628. IPD Sharing: YES. Countries: 1. Publications: 1.
Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis
ClinicalTrials.gov study NCT03029143. IPD Sharing: YES. Countries: 2. Publications: 1.
A Study to Observe Vedolizumab and Anti-tumour Necrosis Factors (Anti-TNFs) Outcomes in Real-world Biologic Ulcerative Colitis (UC) and Crohn's Disease (CD) Participants
ClinicalTrials.gov study NCT03710486. IPD Sharing: YES. Countries: 2. Publications: 1.
Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease (CD)
ClinicalTrials.gov study NCT02611817. IPD Sharing: YES. Countries: 30. Publications: 1.
An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis
ClinicalTrials.gov study NCT02497469. IPD Sharing: YES. Countries: 34. Publications: 3.
Vedolizumab (Anti-alpha4beta7) in Subjects With HIV Infection Undergoing Analytical Treatment Interruption
ClinicalTrials.gov study NCT02788175. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
ClinicalTrials.gov study NCT00783718. IPD Sharing: Not stated. Countries: 3. Publications: 14.
A Dose-Finding Study of Vedolizumab for Treatment of Steroid-Refractory Acute Intestinal Graft-Versus-Host Disease (GvHD) in Participants Who Have Undergone Allogeneic Hematopoietic Stem Cell Transpla
ClinicalTrials.gov study NCT02993783. IPD Sharing: YES. Countries: 5. Publications: 1.
Long Term Safety of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's Disease
ClinicalTrials.gov study NCT00619489. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
ClinicalTrials.gov study NCT01224171. IPD Sharing: Not stated. Countries: 2. Publications: 6.
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease
ClinicalTrials.gov study NCT00783692. IPD Sharing: Not stated. Countries: 3. Publications: 9.
Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease
ClinicalTrials.gov study NCT02425111. IPD Sharing: Not stated. Countries: 8. Publications: 3.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.